TAILIEUCHUNG - A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma

It is of great urgency to explore useful prognostic markers for patients with clear cell renal cell carcinoma (ccRCC). Prognostic models based on ferroptosis-related gene (FRG) in ccRCC is poorly reported for now. | Chen et al. BMC Cancer 2022 22 1 https s12885-021-09033-7 RESEARCH Open Access A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma Siteng Chen1 Encheng Zhang1 Tuanjie Guo1 Jialiang Shao1 Tao Wang1 Ning Zhang2 Xiang Wang1 and Junhua Zheng1 Abstract Background It is of great urgency to explore useful prognostic markers for patients with clear cell renal cell carci- noma ccRCC . Prognostic models based on ferroptosis-related gene FRG in ccRCC is poorly reported for now. Methods Comprehensive analysis of 22 FRGs were performed in 629 ccRCC samples from two independent patient cohorts. We carried out least absolute shrinkage and selection operator analysis to screen out prognosis-related FRGs and constructed prognosis model for patients with ccRCC. Weighted gene co-expression network analysis was also carried out for potential functional enrichment analysis. Results Based on the TCGA cohort a total of 11 prognosis-associated FRGs were selected for the construction of the prognosis model. Significantly differential overall survival hazard ratio 95 CI p Chen et al. BMC Cancer 2022 22 1 Page 2 of 11 malignant cases in renal 3 . As one of the most aggres- of iron-dependent lipid hydroperoxides 6 . Current sive malignancies ccRCC is responsible for most of the studies have also reported the important role of ferrop- death cases caused by renal tumor 4 . Even for local- tosis-related gene FRG in ccRCC. Through facilitat- ized cases about 25 of patients with ccRCC could ing ferroptosis SUV39H1 deficiency could restrain cell also be troubled by tumor recurrence after receiving growth of ccRCC in vitro and in vivo 7 . Reduced expres- operative treatment 5 . Tumor staging system is cur- sion of NCOA4 which is one of the FRG was reported to rently the most fashionable method for survival pre- be associated with tumor progression and poor prognosis diction of

• Y khoa - Dược
• BMC Cancer
• Clear cell renal cell carcinoma
• Cell cycle
• Ferroptosis related gene
• Tumor staging system
• Nuclear division pathway
• Cancer patient pathways
• Colorectal cancer
• Lung cancer
• Breast cancer
• Prostate cancer
• Ovarian cancer
• Cancer detection
• Ovarian cancer symptoms
• Ovarian cancer signs
• Ovarian cancer tests
• Cancer biomarkers
• Pediatric cancer
• Familial cancer predisposition
• Hereditary cancer syndrome
• Genetic cancer susceptibility
• Advanced cancer
• Biliary tract cancer
• Multimodal intervention
• Pancreatic cancer
• Physical activity
• Breast cancer screening
• Familial breast cancer
• Young breast cancer survivors
• High risk relatives
• Randomized trial
• Childhood cancer
• Childhood cancer survivor
• Thyroid cancer screening
• Secondary cancer
• Cancer screening
• Community awareness
• Cancer education
• Cervical cancer
• Prior cancer
• Cancer survivors
• Cancer registry
• Second cancer
• Surgical oncology
• Cancer imaging
• Radiation oncologists
• Medical oncologists
• Oesophagogastric cancer
• Liver cancer
• Hepatobiliary cancer
• Multidisciplinary rehabilitation
• EGFR mutation
• Family history of cancer
• Inherited susceptibility
• Cancer predisposition genes
• Lung cancer aetiology
• Cancer stem cells
• Oct4 overexpressing lung cancer
• Human lung cancer xenograft model
• Disease free survivals
• Cancer hallmarks
• Cancer genesis
• Defiant disease
• Mutational signature
• Cancer diagnosis
• Cancer genomics
• Molecular medicine
• Whole genome sequencing
• Cancer susceptibility gene
• Breast cancer prognosis
• Next generation sequencing
• Quality of care
• Quality indicators
• Shifting cancer care
• German cancer society
• Colorectal cancer screening
• Stomach cancer screening
• Lung cancer survivor
• Physician recommendation
• Total number of lymph nodes
• Lymph node ratio
• Left colon cancer
• Right colon cancer
• Overall survival
• Cumulative incidence
• Esophageal cancer
• Head and neck cancer
• Metachronous cancer
• Young onset
• Reproductive cancer
• Risk factor
• Early detection of cancer
• Gastric cancer incidence
• Population based specialized registry
• Gastric cancer survival
• Gastric cancer clinical characteristics
• Gastric cancer pathological characteristics
• Lung Cancer Screening
• Racial disparities
• Lung Cancer diagnosis
• Screening adherence
• Second primary colorectal cancer
• Standardized incidence ratio
• Left sided colon cancer
• Right sided colon cancer
• Quality of cancer care
• Population based study